Renascience - Page 3

News

2023.05.08 news
Notice of Publication of Article on Diagnostic Agent for Phenylketonuria
2023.04.04 news
Notice of New FAQ Page
2023.03.15 news
Notice of Phase II Trial for Interstitial Lung Disease in Patients with Systemic Scleroderma
2023.03.01 news
Notice of Publication of Article about our Research and Development Center (TREx) that is Based on “Agreement on Development of Local Economic between Sendai City and Tohoku University”
2023.01.20 news
Notice of Publication of Article on the Development of AI with Tohoku University through Open Innovation
2022.12.28 news
Notice of Publication of Article Related to Software as a Medical Device for Diagnosis of Impaired Swallowing Function from Voice

IR News

2024.12.06Timely Disclosure
Notice of Revision of Full-Year Earnings Forecasts for the Fiscal Year Ending March , 2025(156KB)
2024.12.03Timely Disclosure
Notice of 2-year extension of the grant period for the Innovative Cancer Medical Practical Research Project by the Japan Agency for Medical Research and Development (AMED)(131KB)
2024.11.25Timely Disclosure
Notice of termination of joint development and option contract with ASKA Pharmaceutical Co., Ltd. regarding PMSPMDD treatment drug(101KB)
2024.11.05Timely Disclosure
Notice of the completion of a joint development agreement with Taipei Medical University (TMU)-Biotech Co., Ltd. (Taipei) for the PAI-1 inhibitor RS5614.(87KB)
2024.10.21Timely Disclosure
Notice of start of clinical performance testing of artificial intelligence (AI) to predict total water removal volume in maintenance hemodialysis patien(137KB)

About Our Company　>>

We would like to give you a brief introduction to Renascience's corporate activities.

Our Strengths

We introduce our business model.

R&D Pipelines

You can view the progress of each project here.

Management

We are pleased to introduce our officers.

FAQ

You can read about frequently asked questions.